Wyoming Healthcare Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Healthcare Weekly.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on December 22, 2025

December 22, 2025

RxSight, Inc. Announces Chief Financial Officer Transition

GlobeNewswire

December 22, 2025

Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

December 22, 2025

TOMI Environmental Solutions Expands Footprint in Cell and Gene Therapy Sector with Multi-Stage SteraMist iHP Implementation at a New Pharmaceutical Manufacturing Site

GlobeNewswire

December 22, 2025

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

GlobeNewswire

December 22, 2025

Celularity Announces Closing of Financing Transactions

GlobeNewswire

December 22, 2025

Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded.

GlobeNewswire

December 22, 2025

Vivos Inc Summarizes Progress in its Animal Therapy Division

GlobeNewswire

December 22, 2025

Tevogen CEO Donates Shares to Support Education for Underprivileged Children

GlobeNewswire

December 22, 2025

AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040

GlobeNewswire

December 22, 2025

Le brevet pour le masitinib dans le traitement de la drépanocyose a été officiellement accordé aux Etats-Unis avec une protection jusqu'en 2040

GlobeNewswire

December 22, 2025

The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS

GlobeNewswire

December 22, 2025

PracticeLink Supports the Next Generation of Clinicians with Fall 2025 First Practice Fund Scholarships

GlobeNewswire

December 22, 2025

Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain

GlobeNewswire

December 22, 2025

Wholeview Wellness Joins the Lumina Therapy Alliance, Expanding Access to In-Person Addiction-Focused Psychotherapy for Employees and Their Families

GlobeNewswire

December 22, 2025

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

GlobeNewswire

December 22, 2025

PeopleOne Health Selected by Orlando Regional REALTOR® Association to Deliver First-of-Its-Kind Healthcare Solution for Realtors

GlobeNewswire

December 22, 2025

OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025

GlobeNewswire

December 22, 2025

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

GlobeNewswire

December 22, 2025

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

December 22, 2025

Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy

GlobeNewswire